John F. Kelly
CIK: 0002020285
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PBH
Prestige Consumer Healthcare Inc.
Director
Discretionary Trading P&L
Holdings
About Kelly John F.
Kelly John F. (SEC CIK 0002020285) files insider reports with the SEC as Director of Prestige Consumer Healthcare Inc. (PBH).
Signal8 holds 2 ownership filings by Kelly John F., all Form 4s, filed between Aug 6, 2025 and Aug 5, 2026. Those filings report 2 transactions, from Aug 5, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kelly John F.'s filings is in TARRYTOWN, NY.
Recent filings by Kelly John F.
Other insiders filing for Prestige Consumer Healthcare Inc. (PBH)
- ZIER DAWN M., Director
- DArecca James, Director
- Clark Celeste A., Director
- BYOM JOHN E, Director
- Sacco Christine, CFO & COO
- Zerillo Jeffrey, Senior VP Operations